Literature DB >> 17035935

The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects?

Ana B F Emiliano1, Thomaz Cruz, Valerie Pannoni, Julie L Fudge.   

Abstract

Oxytocin (OT) is a neuropeptide synthesized in the paraventricular (PVN) and supraoptic nuclei (SON) in the hypothalamus. Although OT is more commonly known for its role in the milk-ejection reflex, in recent years research has indicated that OT participates in the expression of social behavior, memory processing, modulation of fear, and stress responses. The demonstration that OT influences affiliative behaviors, such as parental care and reproduction, and decreases anxiety has lead to speculations that it may have a role in mood disorders. Evidence from pharmacologic studies, pointing out the modulation of the OT system by serotonin, has argued in favor of OT as a mediator of serotonin reuptake inhibitors (SSRIs) antidepressant properties. In the present study, we investigated the distribution and overlap of OT-labeled cells and serotonin transporter (5-HTT) immunoreactive (IR) fibers in the Macaque hypothalamus, utilizing immunocytochemical and double-immunofluorescent techniques. Consistent with previous reports, the distribution of OT-labeled cells in the hypothalamus is confined to the PVN and SON. In these nuclei, we demonstrate that the distribution of 5-HTT-labeled fibers follows the distribution of OT-labeled cells. Overlap of OT-labeled neurons and 5-HTT-IR fibers occurs in the parvicellular, magnocellular, dorsal, and posterior subdivisions of the PVN. In the SON, 5-HTT-labeled fibers and OT-labeled cells overlap in the ventromedial subdivision and in the 'capsular' part of the dorsolateral SON. These findings provide neuroanatomic support for the idea that SSRIs' therapeutic effects on social affiliation and anxiety may be mediated in part through components of the OT system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035935     DOI: 10.1038/sj.npp.1301206

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  36 in total

1.  Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.

Authors:  Elizabeth Hammock; Jeremy Veenstra-VanderWeele; Zhongyu Yan; Travis M Kerr; Marianna Morris; George M Anderson; C Sue Carter; Edwin H Cook; Suma Jacob
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-05-26       Impact factor: 8.829

2.  The effects of gestational stress and Selective Serotonin reuptake inhibitor antidepressant treatment on structural plasticity in the postpartum brain--A translational model for postpartum depression.

Authors:  Achikam Haim; Christopher Albin-Brooks; Morgan Sherer; Emily Mills; Benedetta Leuner
Journal:  Horm Behav       Date:  2015-05-18       Impact factor: 3.587

3.  Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Authors:  Kai Macdonald; David Feifel
Journal:  Acta Neuropsychiatr       Date:  2011-12-19       Impact factor: 3.403

4.  Implicit association to infant faces: Genetics, early care experiences, and cultural factors influence caregiving propensities.

Authors:  Vincenzo Paolo Senese; Kazuyuki Shinohara; Gianluca Esposito; Hirokazu Doi; Paola Venuti; Marc H Bornstein
Journal:  Behav Brain Res       Date:  2016-09-17       Impact factor: 3.332

5.  No association between oxytocin or prolactin gene variants and childhood-onset mood disorders.

Authors:  John S Strauss; Natalie L Freeman; Sajid A Shaikh; Agnes Vetró; Eniko Kiss; Krisztina Kapornai; Gabriella Daróczi; Timea Rimay; Viola Osváth Kothencné; Edit Dombovári; Emília Kaczvinszk; Zsuzsa Tamás; Ildikó Baji; Márta Besny; Julia Gádoros; Vincenzo DeLuca; Charles J George; Emma Dempster; Cathy L Barr; Maria Kovacs; James L Kennedy
Journal:  Psychoneuroendocrinology       Date:  2010-05-23       Impact factor: 4.905

Review 6.  Differences in how macaques monitor others: Does serotonin play a central role?

Authors:  Hannah Weinberg-Wolf; Steve W C Chang
Journal:  Wiley Interdiscip Rev Cogn Sci       Date:  2019-02-18

Review 7.  Potential of Oxytocin in the Treatment of Schizophrenia.

Authors:  Paul D Shilling; David Feifel
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

8.  Fibroblast growth factor 2 alters the oxytocin receptor in a developmental model of anxiety-like behavior in male rat pups.

Authors:  Yoav Litvin; Cortney A Turner; Mariel B Rios; Pamela M Maras; Sraboni Chaudhury; Miriam R Baker; Peter Blandino; Stanley J Watson; Huda Akil; Bruce McEwen
Journal:  Horm Behav       Date:  2016-09-28       Impact factor: 3.587

Review 9.  Oxytocin and postpartum depression: delivering on what's known and what's not.

Authors:  Sohye Kim; Timothy A Soeken; Sara J Cromer; Sheila R Martinez; Leah R Hardy; Lane Strathearn
Journal:  Brain Res       Date:  2013-11-14       Impact factor: 3.252

Review 10.  From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

Authors:  I S McGregor; P D Callaghan; G E Hunt
Journal:  Br J Pharmacol       Date:  2008-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.